Although antibodies are a key resource in biomedical research, no community-accepted standards exist to rigorously characterize their quality. In 2019, Laflamme et al. developed a procedure to ...

A new study led by Hans-Martin Jäck of the Friedrich-Alexander University Erlangen-Nuremberg in Germany engineered clusters of neutralizing monoclonal antibodies using a transgenic mouse model. A ...

Contact stirring, however, demonstrates just one type of stress that can occur while therapeutic proteins are purified, manufactured, and packaged. Overhead stirring, capillary shear stress, ...

Goal of the ACS Recharge Facility: The goal of the Antibody Characterization and Serology (ACS) Recharge Facility is to offer research reagents, multiplex immunoassays and high-throughput technologies ...

Background. Only Clostridium botulinum strain IBCA10-7060 produces the recently described novel botulinum neurotoxin type H (BoNT/H). BoNT/H (N-terminal two-thirds most homologous to BoNT/F and ...

Researchers at the Olivia Newton-John Cancer Research Institute and collaborators have developed a new anti-HER2 monoclonal antibody, mAb104, which targets a conformationally exposed, tumor-specific ...

BALTIMORE--(BUSINESS WIRE)--Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers ...

Monoclonal antibodies (Mabs) are a potential key component for the treatment of cancer, because of their specificity and multiple effector functions. Hybridoma technology and progress in genetic ...

Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious diseases like ...

DUBLIN--(BUSINESS WIRE)--The "Monoclonal Antibody Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive listing ...